Risks of infection and protective strategies for the asplenic patient

Infectious Diseases in Clinical Practice

Volumn 5, Issue 2, 1996, Pages 94-100

  Styrt, Barbara A ^a,b  

^a Center for Drug Evaluation and Research   (United States)

^b Occupational Epidemiology Branch   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; BENZATHINE PENICILLIN; CEFTRIAXONE; COTRIMOXAZOLE; HAEMOPHILUS VACCINE; MENINGOCOCCUS VACCINE; PENICILLIN G; PNEUMOCOCCUS VACCINE;

ASPLENIA; HUMAN; INFECTION RISK; ORAL DRUG ADMINISTRATION; POSTOPERATIVE INFECTION; REVIEW; SEPSIS;

EID: 0030000536     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019048-199602000-00002     Document Type: Review

References (42)

1. Fielding AK. Prophylaxis against late infection following splenectomy and bone marrow transplant. Blood Rev 1994;8:179-91.
2. Reid MM. Splenectomy, sepsis, immunisation, and guidelines. Lancet 1994;344:970-1.
3. McMullin M, Johnston G. Long-term management of patients after splenectomy. BMJ 1993;307:1372-3.
4. Styrt B. Complications of asplenia and hyposplenism: persistent uncertainties. West J Med 1992;157:461-3.
5. Styrt B. Infection associated with asplenia: risks, mechanisms, and prevention. Am J Med 1990;88(Suppl):33N-42N.
6. Pabst R, Westermann J, Rothkoetter HJ. Immunoarchitecture of regenerated splenic and lymph node transplants. Int Rev Cytol 1991;128:215-60.
7. Pisters PWT, Pachter HL. Autologous splenic transplantation for splenic trauma. Ann Surg 1994;219:225-35.
8. Cullingford GL, Watkins DN, Watts ADJ, Mallon DF. Severe late postsplenectomy infection. Br J Surg 1991;78: 716-21.
9. Cole JT, Flaum MA. Postsplenectomy infections. South Med J 1992;85:1220-6.
10. Wong WY, Overturf GD, Powars DR. Infection caused by Streptococcus pneumoniae in children with sickle cell disease: epidemiology, immunologic mechanisms, prophylaxis, and vaccination. Clin Infect Dis 1992;14:1124-36.
11. Frezzato M, Castaman G, Rodeghiero F. Fulminant sepsis in adults splenectomized for Hodgkin's disease. Haematologica 1993;78(2 Suppl):73-7.
12. Rodeghiero F, Frezzato M, Schiavotto C, Castaman G, Dini E. Fulminant sepsis in adults splenectomized for idiopathic thrombocytopenic purpura. Haematologica 1992;77:253-6.
13. Schilling RF. Estimating the risk for sepsis after splenectomy in hereditary spherocytosis. Ann Intern Med 1995; 122:187-8.
14. Bennett NM, Buffington J, LaForce FM. Pneumococcal bacteremia in Monroe County, New York. Am J Public Health 1992;82:1513-6.
15. Haglund LA, Istre GR, Pickett DA, Welch DF, Fine DP, Pneumococcus Study Group. Invasive pneumococcal disease in central Oklahoma: emergence of high-level penicillin resistance and multiple antibiotic resistance. J Infect Dis 1993;168:1532-6.
16. American Academy of Pediatrics. Immunization in special clinical circumstances. Asplenic children. In: Peter G, editor. 1994 red book: report of the Committee on Infectious Diseases. 23rd ed. Elk Grove Village (IL): The Academy, 1994:57-8.
17. [Anonymous]. Hemorrhage and shock associated with invasive pneumococcal infection in health infants and children: New Mexico, 1993-1994. MMWR Morb Mortal Wkly Rep 1995;43:949-52.
18. Advisory Committee on Immunization Practices. General recommendations on immunization. MMWR Morb Mortal Wkly Rep 1994;43(RR-1).
19. ACP Task Force on Adult Immunization, Infectious Diseases Society of America. Immunizations for immunocompromised adults. Splenic disorders. In: Guide for adult immunization. 3rd ed. Philadelphia: American College of Physicians, 1994:54-5.
20. Hirschmann JV, Lipsky BA. The pneumococcal vaccine after 15 years of use. Arch Intern Med 1994;154:373-7.
21. Fedson DS, Shapiro ED, LaForce FM, Mufson MA, Musher DM, Spika JS, et al. Pneumococcal vaccine after 15 years of use. Another view. Arch Intern Med 1994;154:2531-5.
22. Butler JC, Breiman RF, Campbell JF, Lipman HB, Broome CV, Facklam RR. Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. JAMA 1993;270:1826-31.
23. Lehne G, Hannisdal E, Langhoms R, Nome O. A 10-year experience with splenectomy in patients with malignant non-Hodgkin's lymphoma at the Norwegian Radium Hospital. Cancer 1994;74:933-9.
24. Jockovich M, Mendenhall NP, Sombeck MD, Talbert JL, Copeland EM III, Bland KI. Long-term complications of laparotomy in Hodgkin's disease. Ann Surg 1994;219: 615-24.
25. Schaad UB, Kaplan SL, McCracken GH Jr. Steroid therapy for bacterial meningitis. Clin Infect Dis 1995;20:685-90.
26. Jackson LA, Schuchat A, Reeves MW, Wenger JD. Serogroup C meningococcal outbreaks in the United States. An emerging threat. JAMA 1995;273:383-9.
27. Pegelow CH, Armstrong FD, Light S, Toledano SR, Davis J. Experience with the use of prophylactic penicillin in children with sickle cell anemia. J Pediatr 1991;118:736-8.
28. Resta RS, Tamaroll MJ, Chasalow F, Lanzkowsky P. Therapeutic adherence to oral medication regimens by adolescents with cancer. I. Laboratory assessment. J Pediatr 1992;120:807-11.
29. Centers for Disease Control and Prevention. Drug-resistant Streptococcus pneumoniae: Kentucky and Tennessee, 1993. MMWR Morb Mortal Wkly Rep 1994;43:23-31.
30. Reichler MR, Allphin AA, Breiman RF, Schreiber JR, Arnold JE, McDougal LK, et al. The spread of multiply-resistant Streptococcus pneumoniae at a day care center in Ohio. J Infect Dis 1992;166:1346-53.
31. Hall EH, Sherman RG, Emmons WW III, Naylor GD. Antibacterial prophylaxis. Dent Clin North Am 1994;38: 707-18.
32. Llibre JM, Cucurull J, Aloy A, Hernandez JA. Antimicrobial prophylaxis for dental extractions after splenectomy. Lancet 1991;337:1485-6.
33. Green AD, Connor MP. Prevention of postsplenectomy sepsis. Lancet 1993;341:1034.
34. Looareesuwan S, Suntharasamai P, Webster HK, Ho M. Malaria in splenectomized patients: report of four cases and review. Clin Infect Dis 1993;16:361-6.
35. Wilimas JA, Flynn PM, Harris S, Day SW, Smith R, Chesney PJ, et al. A randomized study of outpatient treatment with ceftriaxone for selected febrile children with sickle cell disease. N Engl J Med 1993;329:472-6.
36. Powell RW, Blaylock WE, Hoff CJ, Chartrand SA. The efficacy of postsplenectomy sepsis prophylactic measures: the role of penicillin. J Trauma 1988;28:1285-7.
37. Dickerman JD, Chalmer B, Horner SR. The effect of penicillin on the mortality of splenectomized mice exposed to an aerosol of Streplococcus pneumoniae type 3. Pediatr Res 1980;14:1139-41.
38. Persing DH, Herwaldt BL, Glaser C, Lane RS, Thomford JW, Mathiesen D, et al. Infection with a babesia-like organism in northern California. N Engl J Med 1995;332: 298-303.
39. White KS, Covington D, Churchill P, Maxwell JG, Norman KS, Clancy TV. Patient awareness of health precautions after splenectomy. Am J Infect Control 1991;19:36-41.
40. Deodhar HA, Marshall RJ, Barnes JN. Increased risk of sepsis after splenectomy. BMJ 1993;307:1408-9.
41. Friedland IR, McCracken GH. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med 1994;331:377-82.
42. Camel JE, Kim KS, Tchejeyan GH, Mahour GH. Efficacy of passive immunotherapy in experimental postsplenectomy sepsis due to Haemophilus influenzae type b. J Pediatr Surg 1993;28:1441-5.